Literature DB >> 15493870

Tapasin and other chaperones: models of the MHC class I loading complex.

Cynthia Anne Wright1, Patrycja Kozik, Martin Zacharias, Sebastian Springer.   

Abstract

MHC (major histocompatibility complex) class I molecules bind intracellular virus-derived peptides in the endoplasmic reticulum (ER) and present them at the cell surface to cytotoxic T lymphocytes. Peptide-free class I molecules at the cell surface, however, could lead to aberrant T cell killing. Therefore, cells ensure that class I molecules bind high-affinity ligand peptides in the ER, and restrict the export of empty class I molecules to the Golgi apparatus. For both of these safeguard mechanisms, the MHC class I loading complex (which consists of the peptide transporter TAP, the chaperones tapasin and calreticulin, and the protein disulfide isomerase ERp57) plays a central role. This article reviews the actions of accessory proteins in the biogenesis of class I molecules, specifically the functions of the loading complex in high-affinity peptide binding and localization of class I molecules, and the known connections between these two regulatory mechanisms. It introduces new models for the mode of action of tapasin, the role of the class I loading complex in peptide editing, and the intracellular localization of class I molecules.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15493870     DOI: 10.1515/BC.2004.100

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  24 in total

Review 1.  Aging and immune function: molecular mechanisms to interventions.

Authors:  Subramaniam Ponnappan; Usha Ponnappan
Journal:  Antioxid Redox Signal       Date:  2011-01-08       Impact factor: 8.401

2.  Comparative molecular dynamics analysis of tapasin-dependent and -independent MHC class I alleles.

Authors:  Florian Sieker; Sebastian Springer; Martin Zacharias
Journal:  Protein Sci       Date:  2007-02       Impact factor: 6.725

Review 3.  Assembly of MHC class I molecules within the endoplasmic reticulum.

Authors:  Yinan Zhang; David B Williams
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 4.  The convergent roles of tapasin and HLA-DM in antigen presentation.

Authors:  Scheherazade Sadegh-Nasseri; Mingnan Chen; Kedar Narayan; Marlene Bouvier
Journal:  Trends Immunol       Date:  2008-02-07       Impact factor: 16.687

Review 5.  Viral proteins interfering with antigen presentation target the major histocompatibility complex class I peptide-loading complex.

Authors:  Gustav Røder; Linda Geironson; Iain Bressendorff; Kajsa Paulsson
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

6.  HLA polymorphism and tapasin independence influence outcomes of HIV and dengue virus infection.

Authors:  Tiziana Di Pucchio; Rafick-Pierre Sekaly
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-25       Impact factor: 11.205

7.  Signal peptides and trans-membrane regions are broadly immunogenic and have high CD8+ T cell epitope densities: Implications for vaccine development.

Authors:  Riva Kovjazin; Ilan Volovitz; Yair Daon; Tal Vider-Shalit; Roy Azran; Lea Tsaban; Lior Carmon; Yoram Louzoun
Journal:  Mol Immunol       Date:  2011-02-12       Impact factor: 4.407

8.  Tapasin and ERp57 form a stable disulfide-linked dimer within the MHC class I peptide-loading complex.

Authors:  David R Peaper; Pamela A Wearsch; Peter Cresswell
Journal:  EMBO J       Date:  2005-09-29       Impact factor: 11.598

9.  Dipeptides catalyze rapid peptide exchange on MHC class I molecules.

Authors:  Sunil Kumar Saini; Heiko Schuster; Venkat Raman Ramnarayan; Hans-Georg Rammensee; Stefan Stevanović; Sebastian Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-22       Impact factor: 11.205

10.  Calreticulin-dependent recycling in the early secretory pathway mediates optimal peptide loading of MHC class I molecules.

Authors:  Christopher Howe; Malgorzata Garstka; Mohammed Al-Balushi; Esther Ghanem; Antony N Antoniou; Susanne Fritzsche; Gytis Jankevicius; Nasia Kontouli; Clemens Schneeweiss; Anthony Williams; Tim Elliott; Sebastian Springer
Journal:  EMBO J       Date:  2009-10-22       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.